A combination of two drugs which can block the growth of cancer cells has shown promising results in women with a form of ...

People with intermediate risk, localised prostate cancer can be treated as effectively using fewer and higher doses of ...

Professor Amy Berrington explains how she and a team of scientists from around the world took on the challenge of updating a classic text for cancer researchers.

Thousands of men could have their prostate cancer diagnosed at an earlier stage when it is easier and cheaper to treat, ...

A new multimillion-pound research programme, involving scientists from The Institute of Cancer Research, London, is aiming to ...

Researchers are a step closer to revolutionising how doctors use radiotherapy to treat patients with muscle-invasive bladder ...

Our excellence in working with industry and academia, and in engaging with the wider public has been highlighted in an important analysis. The latest Knowledge Exchange Framework – ‘KEF’ for short – ...

Professor Martin Kaiser is the Chair of Haematology, group leader of the Myeloma Molecular Therapy group, and an Honorary Consultant Haematologist at The Royal Marsden NHS Foundation Trust. Group: ...

Scientists have developed a new clinical pathway for testing for the cancer-causing faults in the BRCA gene that could ensure patients get the right treatment and boost the number of people who get ...

This news story is also explained in our recent blog post: Small numbers, big impact: the unique challenges of studying rare cancers Chemotherapy halves the risk of a rare form of kidney cancer coming ...

A charity fundraising event that was set up as a tribute to Dave Myers, the much-loved TV chef, raised an incredible £63,169.32 for The Institute of Cancer Research, London. Dave, who was one half of ...